Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Chirality in Nature02:30

Chirality in Nature

13.4K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
13.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment framework.

Frontiers in digital health·2026
Same author

Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Human organoids: Fit for drug discovery?

Stem cell reports·2026
Same author

Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosis.

Patterns (New York, N.Y.)·2026
Same author

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids.

Nature communications·2026
Same author

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.

Cell·2026

相关实验视频

Updated: Jun 26, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K

从药物发现的角度探索 SureChEMBL.

Yojana Gadiya1,2,3, Simran Shetty4,5,6, Martin Hofmann-Apitius7,8

  • 1Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525, Hamburg, Germany. Yojana.Gadiya@itmp.fraunhofer.de.

Scientific data
|May 16, 2024
PubMed
概括

这项研究分析了SureChEMBL的专利数据,以确定潜在的候选药物. 我们评估药物相似性和开发阶段的化合物,帮助制药药物发现.

更多相关视频

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

相关实验视频

Last Updated: Jun 26, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

科学领域:

  • 制药化学 制药化学 制药化学
  • 药用化学 医学化学
  • 药物发现信息学 药物发现信息学

背景情况:

  • 药物开发是昂贵的,因此专利保护至关重要.
  • 分析专利文件有助于确定新药候选者的操作自由.
  • 公共存储库提供自动化方法来提取治疗剂信息.

研究的目的:

  • 在SureChEMBL.中提供专利化合物的全面概述.
  • 评估这些化合物对制药药物发现的重要性.
  • 根据药物相似性和临床开发阶段来评估化合物.

主要方法:

  • 探索了 SureChEMBL,这是一个生命科学公共专利数据库.
  • 在公共化学数据资源中识别了专利化合物.
  • 在专利文件中标点化学注释.
  • 对药物相似性标准进行评估的化合物.
  • 检查了临床成功的药物开发阶段.

主要成果:

  • 从SureChEMBL数据库中对专利化合物进行了目录.
  • 评估已识别的化合物的药物相似性和潜力.
  • 分析了这些制药化合物的临床开发状态.
  • 提供了关于SureChEMBL化合物的药物发现相关性的见解.

结论:

  • SureChEMBL是识别生命科学中的专利化合物的宝贵资源.
  • 该研究展示了从专利数据中评估候选药物潜力的方法.
  • 这些发现有助于了解与制药药物发现相关的化合物的景观.